Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuzhiqing ointment for perianal chronic eczema
ChiCTR2000038764Phase 4Not yet recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Sep 2020
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Fuzhiqing in dermatitis (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: Pruritus score, EASI and 2 more. Planned start Sep 2020; status: not yet recruiting.
02
Drugs
Fuzhiqing
03
Conditions
dermatitis
Beyond the preview
Go deeper on ChiCTR2000038764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038764.